American International Group, Inc. Evolus, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.99 - $14.91 $919 - $1,371	92 Added 0.45%	20,674 $289,000
Q4 2023 Feb 13, 2024	SELL	$7.6 - $10.53 $630 - $873	-83 Reduced 0.4%	20,582 $216,000
Q3 2023 Nov 13, 2023	BUY	$7.15 - $10.2 $5,248 - $7,486	734 Added 3.68%	20,665 $188,000
Q2 2023 Aug 04, 2023	BUY	$7.23 - $10.52 $20,525 - $29,866	2,839 Added 16.61%	19,931 $144,000
Q1 2023 May 12, 2023	BUY	$7.81 - $11.05 $2,663 - $3,768	341 Added 2.04%	17,092 $144,000
Q4 2022 Feb 10, 2023	SELL	$6.52 - $8.95 $404 - $554	-62 Reduced 0.37%	16,751 $125,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $1,854 - $3,279	239 Added 1.44%	16,813 $135,000
Q2 2022 Aug 12, 2022	BUY	$10.22 - $13.94 $930 - $1,268	91 Added 0.55%	16,574 $192,000
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $6,055 - $13,664	-1,160 Reduced 6.57%	16,483 $185,000
Q4 2021 Feb 11, 2022	SELL	$5.37 - $8.38 $1,074 - $1,676	-200 Reduced 1.12%	17,643 $115,000
Q3 2021 Nov 12, 2021	SELL	$7.36 - $13.67 $1,700 - $3,157	-231 Reduced 1.28%	17,843 $136,000
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $45,341 - $75,174	5,385 Added 42.44%	18,074 $229,000
Q1 2021 May 07, 2021	BUY	$3.2 - $16.51 $105 - $544	33 Added 0.26%	12,689 $165,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $1,059 - $1,756	-363 Reduced 2.79%	12,656 $43,000
Q3 2020 Nov 04, 2020	SELL	$3.03 - $5.48 $896 - $1,622	-296 Reduced 2.22%	13,019 $51,000
Q2 2020 Aug 12, 2020	BUY	$3.53 - $6.17 $8,390 - $14,666	2,377 Added 21.73%	13,315 $71,000
Q1 2020 May 04, 2020	SELL	$3.53 - $12.21 $2,223 - $7,692	-630 Reduced 5.45%	10,938 $45,000
Q4 2019 Feb 05, 2020	BUY	$11.58 - $17.37 $23,495 - $35,243	2,029 Added 21.27%	11,568 $141,000
Q3 2019 Nov 08, 2019	BUY	$13.91 - $19.87 $34,635 - $49,476	2,490 Added 35.32%	9,539 $149,000
Q2 2019 Aug 13, 2019	BUY	$13.19 - $28.36 $14,667 - $31,536	1,112 Added 18.73%	7,049 $103,000
Q1 2019 May 06, 2019	SELL	$12.43 - $28.91 $2,386 - $5,550	-192 Reduced 3.13%	5,937 $134,000
Q4 2018 Feb 13, 2019	BUY	$10.57 - $19.29 $951 - $1,736	90 Added 1.49%	6,129 $73,000
Q3 2018 Nov 09, 2018	BUY	$17.31 - $29.82 $47,515 - $81,855	2,745 Added 83.33%	6,039 $112,000
Q2 2018 Aug 08, 2018	BUY	$6.85 - $38.49 $445 - $2,501	65 Added 2.01%	3,294 $92,000
Q1 2018 May 07, 2018	BUY	$8.34 - $12.5 $26,929 - $40,362	3,229 New	3,229 $29,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

Perceptive Advisors LLC New York, NY

5.36M
Shares

$58.1 Million
2.27% of portfolio
Tang Capital Management LLC San Diego, CA

4.85M
Shares

$52.5 Million
6.69% of portfolio
Black Rock Inc. New York, NY

4.01M
Shares

$43.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.2M
Shares

$34.6 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.82M
Shares

$30.6 Million
2.72% of portfolio

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account